Indivior PLC
INDV30.880USD
-0.460-1.47%
Handelsschluss 11/10, 16:00（ET）Kurse um 15 Minuten verzögert
3.86BMarktkapitalisierung
33.57KGV TTM
mehr Informationen über Indivior PLC Unternehmen
Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.
Indivior PLC Informationen
BörsenkürzelINDV
Name des UnternehmensIndivior PLC
IPO-datumDec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
Anzahl der mitarbeiter1030
WertpapierartOrdinary Share
GeschäftsjahresendeDec 24
Addresse234 Bath Road
StadtSLOUGH
BörseNASDAQ Global Select Consolidated
LandUnited Kingdom
PostleitzahlSL1 4EE
Telefon448043791090
Websitehttps://www.indivior.com/en
BörsenkürzelINDV
IPO-datumDec 24, 2014
CEOMr. Joseph J. (Joe) Ciaffoni
Führungskräfte von Indivior PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
256.00M
84.77%
Rest of World
46.00M
15.23%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Aug 15
Aktualisiert: Fri, Aug 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.46%
Two Seas Capital LP
7.41%
Goldman Sachs International
7.19%
BlackRock Investment Management (UK) Ltd.
6.62%
Andere
61.50%
Aktionäre
Aktionäre
Anteil
Oaktree Capital Management, L.P.
8.82%
Deerfield Management Company, L.P.
8.46%
Two Seas Capital LP
7.41%
Goldman Sachs International
7.19%
BlackRock Investment Management (UK) Ltd.
6.62%
Andere
61.50%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
40.46%
Investment Advisor/Hedge Fund
24.19%
Investment Advisor
15.17%
Research Firm
13.06%
Individual Investor
3.87%
Pension Fund
0.44%
Bank and Trust
0.31%
Family Office
0.31%
Insurance Company
0.04%
Andere
2.14%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
372
118.02M
94.53%
+2.51M
2025Q2
354
123.13M
98.21%
+4.02M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Oaktree Capital Management, L.P.
11.01M
8.82%
--
--
Jun 30, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
--
--
Jun 30, 2025
Two Seas Capital LP
10.33M
8.28%
-1.33M
-11.43%
Sep 03, 2025
Goldman Sachs International
8.97M
7.19%
+759.17K
+9.24%
Jun 30, 2025
BlackRock Investment Management (UK) Ltd.
8.27M
6.63%
+8.24M
+28135.71%
Jun 27, 2025
Madison Avenue Partners LP
7.92M
6.35%
+130.09K
+1.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.04M
4.04%
+5.03M
+68055.48%
Jun 30, 2025
Rubric Capital Management LP
4.65M
3.72%
-55.00K
-1.17%
Jun 30, 2025
Point72 Asset Management, L.P.
3.57M
2.86%
+1.69M
+89.42%
Jun 30, 2025
The Vanguard Group, Inc.
5.63M
4.51%
+1.02M
+22.15%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
Lattice Hartford Multifactor Small Cap ETF
0.84%
Federated Hermes MDT Small Cap Core ETF
0.36%
Janus Henderson Small Cap Growth Alpha ETF
0.35%
ProShares Ultra Nasdaq Biotechnology
0.31%
Invesco Nasdaq Biotechnology ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.27%
Vanguard US Multifactor ETF
0.24%
Pacer US Small Cap Cash Cows ETF
0.22%
First Trust Active Factor Small Cap ETF
0.22%
Principal U.S. Small-Cap ETF
0.16%
Mehr Anzeigen
Lattice Hartford Multifactor Small Cap ETF
Anteil0.84%
Federated Hermes MDT Small Cap Core ETF
Anteil0.36%
Janus Henderson Small Cap Growth Alpha ETF
Anteil0.35%
ProShares Ultra Nasdaq Biotechnology
Anteil0.31%
Invesco Nasdaq Biotechnology ETF
Anteil0.3%
Franklin US Small Cap Multifactor Index ETF
Anteil0.27%
Vanguard US Multifactor ETF
Anteil0.24%
Pacer US Small Cap Cash Cows ETF
Anteil0.22%
First Trust Active Factor Small Cap ETF
Anteil0.22%
Principal U.S. Small-Cap ETF
Anteil0.16%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
